Precithera

Developer of precision medicine for rare genetic bone diseases

placeMontreal, Montreal, Canada calendar_todayFounded 2016 groups4 employees language precithera.com

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 22 times.

YearFilings
20181
20192
20201

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital467%
Private equity117%
Other / undisclosed117%
Coming soon